One Health Company presented its first results of development in the Eastern region for patients with Alopecia areata (AA) at The First Barcelona Hair Congress. The researchers' goals were collecting epidemiological, anamnestic, clinical and psychosomatic data in AA Eastern patients and, moreover, further creation of an single registry of patients for their proper management, sharing and compiling the information, more accurate assessing of the efficacy and safety of the most advanced treatments for AA.
The Meeting is now over and we believe that it was a great success.
